trio-smart
Commercial- Indications
- SIBO, Gut health assessment
Company intelligence / Profile preview
Gemelli Biotech
Raleigh, North Carolina, United Statesgemellibiotech.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Gemelli Biotech develops and commercializes non-invasive precision diagnostics focused on gastrointestinal diseases. Its flagship products include ibs-smart®, an ELISA-based blood test that measures anti-CdtB and anti-vinculin antibodies to diagnose post-infectious IBS with high certainty, and trio-smart®, a breath test that uniquely measures hydrogen, methane, and hydrogen sulfide to aid diagnosis of SIBO, IMO, excess hydrogen sulfide conditions, and carbohydrate malabsorption. Both tests are available in the US with pilot programs internationally. The company has raised significant venture funding to expand commercialization.
- Therapeutic areas
- Gastroenterology
- Modalities
- Diagnostic test (ELISA blood test)Diagnostic device (Breath test)Non-pharmacological therapy (Diagnostics only; not therapeutics)
- Industry
- Protein Biomarker Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Medically Associated Science & Technology program at Cedars-Sinai Medical Center
Beyond the preview
Go deeper on Gemelli Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gemelli Biotech.